Prasanth Ganesan

32PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesPredictive and prognostic markersOral medicine and pathologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 31, 2026
Dexamethasone-Free Antiemetic Prophylaxis for Children and Adolescents Receiving Highly Emetogenic Chemotherapy: A Multicenter, Phase III, Noninferiority Trial (CIVIC POD).

|Jul 29, 2026
Outcomes of Adults Age 40 Years and Older With Newly Diagnosed ALL: A Multicenter Registry Analysis From the Hematology Cancer Consortium.

|May 27, 2026
Primary Platinum-Resistant Ovarian Cancer: Clinicopathologic Correlates and Outcomes From a Multicenter Prospective Indian Registry.

|Dec 25, 2025
Intensive Oral Hygiene Interventions during Therapy of Acute Leukemia May Result in Detrimental Outcomes: A Randomized Clinical Trial.

Biswajit Dubashi, Nirmal Pratap Mote, B Krishnan

|Dec 19, 2025
Comparison of Survival Outcomes Among Patients Receiving Chemotherapy with Secondary Cytoreductive Surgery Versus Chemotherapy Alone for Recurrent Epithelial Ovarian, Tubal, or Peritoneal Carcinoma: a Propensity Score-matched Cohort Study.

Anjali Singh, Prasanth Penumadu, Prasanth Ganesan

|Sep 16, 2024
Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India.

Chepsy Philip, Sushil Selvarajan, Lingaraj Nayak

Pageof 6

Frequent Collaborators

4 joint publications

Amit Sehrawat

4 joint publications

Manju Sengar

3 joint publications

Laltendu Moharana

3 joint publications

Prasanth Penumadu